126 related articles for article (PubMed ID: 17995941)
1. Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.
Lee JL; Ryu MH; Chang HM; Kim TW; Lee SS; Sym SJ; Kim MK; Kim KM; Lee JS; Kang YK
J Gastroenterol Hepatol; 2008 May; 23(5):811-6. PubMed ID: 17995941
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.
Zhu AX; Fuchs CS; Clark JW; Muzikansky A; Taylor K; Sheehan S; Tam K; Yung E; Kulke MH; Ryan DP
Oncologist; 2005; 10(6):392-8. PubMed ID: 15967833
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.
Lee J; Park JO; Kim WS; Park SH; Park KW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Joh J; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Park K
Cancer Chemother Pharmacol; 2004 Nov; 54(5):385-90. PubMed ID: 15248028
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.
Iwasa S; Morizane C; Okusaka T; Ueno H; Ikeda M; Kondo S; Tanaka T; Nakachi K; Mitsunaga S; Kojima Y; Hagihara A; Hiraoka N
Jpn J Clin Oncol; 2010 Apr; 40(4):313-8. PubMed ID: 20047862
[TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.
Ikeda M; Okusaka T; Ueno H; Morizane C; Iwasa S; Hagihara A; Kojima Y
Oncology; 2007; 72(3-4):188-93. PubMed ID: 18097170
[TBL] [Abstract][Full Text] [Related]
7. Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma.
Cheng AL; Chen YC; Yeh KH; Chuang SE; Chen BR; Chen DS
Cancer; 1996 Mar; 77(5):872-7. PubMed ID: 8608477
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.
Yang TS; Chang HK; Chen JS; Lin YC; Liau CT; Chang WC
J Gastroenterol; 2004; 39(4):362-9. PubMed ID: 15168248
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
[TBL] [Abstract][Full Text] [Related]
10. Influence of the etiology of liver cirrhosis on the response to combined intra-arterial chemotherapy in patients with advanced hepatocellular carcinoma.
Kanayama M; Nagai H; Sumino Y
Cancer Chemother Pharmacol; 2009 Jun; 64(1):109-14. PubMed ID: 18979100
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC).
Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
Hepatogastroenterology; 2008; 55(85):1380-4. PubMed ID: 18795694
[TBL] [Abstract][Full Text] [Related]
13. Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy.
Momiyama K; Nagai H; Sumino Y
Cancer Chemother Pharmacol; 2009 Jul; 64(2):271-7. PubMed ID: 19011857
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma.
Lind PA; Naucler G; Holm A; Gubanski M; Svensson C
Acta Oncol; 2007; 46(2):230-3. PubMed ID: 17453374
[TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
Hamada A; Yamakado K; Nakatsuka A; Takaki H; Akeboshi M; Takeda K
J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma.
Uhm JE; Park JO; Lee J; Park YS; Park SH; Yoo BC; Paik SW; Koh KC; Kang WK; Lim HY
Cancer Chemother Pharmacol; 2009 Apr; 63(5):929-35. PubMed ID: 18726098
[TBL] [Abstract][Full Text] [Related]
17. [A case with hepatocellular carcinoma effectively treated by continuous hepatic arterial infusion of etoposide, epirubicin and CDDP].
Tarusawa K; Yodono H; Ikami I; Sasaki T; Kanehira J; Takahashi S; Shibutani K; Noda H; Shinohara A; Takekawa D
Gan To Kagaku Ryoho; 1992 Mar; 19(3):383-6. PubMed ID: 1311915
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma.
Petrini I; Lencioni M; Ricasoli M; Iannopollo M; Orlandini C; Oliveri F; Bartolozzi C; Ricci S
Cancer Chemother Pharmacol; 2012 Mar; 69(3):773-80. PubMed ID: 22033636
[TBL] [Abstract][Full Text] [Related]
19. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
Casanova M; Massimino M; Ferrari A; Spreafico F; Piva L; Coppa J; Luksch R; Cefalo G; Terenziani M; Polastri D; Bellani FF; Mazzaferro V
Pediatr Hematol Oncol; 2005; 22(3):189-98. PubMed ID: 16020101
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
